Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Courses
  4. ESMO Advanced Course on Biomarkers for Precision Medicine 2022: Singapore

Session 5 - Molecular tumour board (ESCAT criteria, performance data from molecular guided trials)

Organisation and role of the molecular tumour board

Date

09 Oct 2022

Session

Session 5 - Molecular tumour board (ESCAT criteria, performance data from molecular guided trials)

Topics

Translational Research

Tumour Site

Presenters

A. Stenzinger, DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Functional interpretation of variants

Presenter: A. H. Wagner, US

Session: Session 5 - Molecular tumour board (ESCAT criteria, performance data from molecular guided trials)

Resources:

Slides

Webcast

Clinical variant interpretation

Presenter: D. S. W. Tan, SG

Session: Session 5 - Molecular tumour board (ESCAT criteria, performance data from molecular guided trials)

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.